Get the Stockscreener App
2.02
4.66%
0.09
iBio Inc stock is traded at $2.02, with a volume of 1.42M.
It is up +4.66% in the last 24 hours and up +88.79% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$1.93
Open:
$1.95
24h Volume:
1.42M
Relative Volume:
0.21
Market Cap:
$45.42M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.3046
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+6.88%
1M Performance:
+88.79%
6M Performance:
+172.97%
1Y Performance:
-16.53%
1-Day Range:
$1.87
$2.12
1-Week Range:
$1.70
$2.12
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.02 | 43.40M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Oppenheimer | Outperform |
| Oct-17-25 | Initiated | Leerink Partners | Outperform |
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
View All
iBio Inc Stock (IBIO) Latest News
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Breakouts Watch: What dividend safety score for iBio Inc stockJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
LifeSci Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
iBio Insiders Placed Bullish Bets Worth US$655.0k - Yahoo Finance
LifeSci Capital Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $5 - 富途牛牛
Will iBio Inc. (0JV0) stock hit analyst forecasts2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - Улправда
Will iBio Inc. stock attract ESG investorsMarket Growth Review & Weekly Breakout Watchlists - DonanımHaber
How institutional buying supports iBio Inc. stockForecast Cut & Accurate Entry/Exit Alerts - Улправда
iBio (IBIO) EV-to-OCF : -0.03 (As of Dec. 18, 2025) - GuruFocus
How iBio Inc. stock performs after earningsAnalyst Upgrade & High Accuracy Trade Alerts - Улправда
Risk Check: Why iBio Inc stock could outperform in 2025Weekly Market Summary & AI Powered Market Trend Analysis - moha.gov.vn
iBio initiated with an Outperform at Oppenheimer - MSN
Best Penny Stocks To ConsiderDecember 10th - MarketBeat
Manufacturing Stocks To ResearchDecember 8th - MarketBeat
3 Penny Stocks to Watch Now, 12/11/25 - TipRanks
Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - ts2.tech
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
iBio: Obesity Solutions to Drive Stock Momentum - StocksToTrade
Biotech Alert: Searches spiking for these stocks today - TipRanks
3 Penny Stocks to Watch Now, 12/9/25 - TipRanks
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025) - ts2.tech
Why is Biotech Stock iBio Up over 50%? - TipRanks
Analyst Upgrade: Will iBio Inc stock outperform international peersQuarterly Trade Review & Accurate Intraday Trading Signals - moha.gov.vn
iBio Rockets: Is It a Mirage or Real Boost? - StocksToTrade
iBio’s New Approach: Game Changer or Just Artifice? - timothysykes.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
iBio (IBIO) Price Target Increased by 14.56% to 4.81 - Nasdaq
Can iBio Inc. stock sustain free cash flow growthJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Is iBio Inc. (0JV0) stock a fit for income portfoliosQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
IBIO: Long-acting antibody pipeline targets obesity gaps, with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Will iBio Inc. (0JV0) stock test record highs in 2025Weekly Risk Summary & Proven Capital Preservation Tips - Newser
IBIO: AI-driven antibody programs target obesity gaps with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Can iBio Inc. stock deliver sustainable ROE2025 Volume Leaders & High Conviction Investment Ideas - Newser
How iBio Inc. stock reacts to oil pricesMarket Movement Recap & High Accuracy Swing Entry Alerts - Newser
Why iBio Inc. (0JV0) stock could rally strongly2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Why iBio Inc. (0JV0) stock trades below fair valueLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How iBio Inc. (0JV0) stock responds to job market shiftsEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Why analysts raise outlook for iBio Inc. (0JV0) stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Pharos iBio Co., Ltd. announced that it expects to receive KRW 19 billion in funding from Korea Investment Partners Co. Ltd. - marketscreener.com
Aug Patterns: Should I hold or sell iBio Inc stock in 2025New Guidance & Proven Capital Preservation Tips - BỘ NỘI VỤ
iBio (IBIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why retail traders accumulate iBio Inc. (0JV0) stockJuly 2025 Breakouts & Verified Entry Point Signals - Newser
How robust is iBio Inc. (0JV0) stock financial positionJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Shorts Report: How institutional buying supports iBio Inc. stockJuly 2025 Reactions & Accurate Entry/Exit Alerts - moha.gov.vn
iBio, Inc. Reports Q3 2025 Financial Results - MSN
What technical charts say about iBio Inc. stockQuarterly Earnings Report & Long-Term Safe Investment Plans - moha.gov.vn
iBio to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
[Form 4] iBio, Inc. Insider Trading Activity - Stock Titan
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):